SPL - Starpharma Holdings

[Dwib]

Hi

Just wondering if anyone had any information about Starpharma (SPL) a Biotech company. Caught my eye because of it's recent success (Phase I) in a trial of it's AIDs prevention gel. I imagine any company that brings out a successful product in preventing AIDs has got to do well in the future. They state that a commercial product is still a few years away. I have added a profile of the company below for those that are interested.

cheers
Dwib



SPL's strategy is to commercialise pharmaceutical applications for dendrimers. Part of this strategy involves a number of alliances with other biotech groups including AGT Biosciences (Type II diabetes) and New Zealand's Industrial Research Limited (IRL).

The collaborative agreement with IRL is for the development of particles and elements that can be used to target drugs to specific sites. As a result of this initiative, the company aims to achieve better performance and fewer side effects in the compounds used in the development. The establishment of this alliance has been supported by the New Zealand Government through its establishment of the Foundation for Research, Science and Technology which has awarded IRL a contract worth NZ$5.9 million over 5 years.


The company's flagship product in clinical development, VivaGel, is a vaginal microbicide product for the prevention of the transmission of major STD's. Phase I human safety trials are underway at Royal Adelaide Hospital which are expected to be completed by the second quarter of 2004.


In September SPL raised $6.9m through a share placement. The funds will be used to accelerate the company's development of its VivaGel product and other existing pipeline products in the respiratory, oncology and exotic disease areas.


In March 2004 SPL elected to relinquish PDF status to increase its investment options. At the same time $7.5m was raised via a placement of shares to Australian and offshore institutions. The funds are earmarked for investment in corporate opportunities arising out of DNT and related entities.

 

[Odduna]

Re: SPL - Starpharma

I see that it has received fast track approval with the FDA in the US.

The $15 million it has raised in December.
Company believes that they have now got enough cash for next 2 years.

Although it seems to be on a 6 month slide at the moment.

 

[CanOz]

This got some press yesterday on ABC. The chart looks good too. I think i might take a medium term position on this.

 

[CanOz]

Thought i would post a chart of this. Its not resources so its a bit out of favour atm, but the biotech sector is tipped to be hot again. Maybe one to watch.

 

[ocelot]

Some very positive news today. Signed a full agreement with Durex to produce Starpharma coated condom's market has jumped 25% on the news. Directors of the company bought a bulk of shares before the annoucement.

 

[bumclouds]

There's been a trade freeze on this stock today.

Does anybody know why?

 

[blackjack]

i am accumulating SPL and got in early last year at 19 cents
now riding 70 cents

this stock has so much potential and at least 5 products each worth billions

2010 will see Durex use the gel in their condoms and so the 100 mill in royalties will flow

the VIVAGEL will be on the market this year and this alone will be worth billions as groups like the Gates foundation will buy this stuff by the container load and ship it off to the poorer AIDS ridden countries

at 70 cents its still cheap.

 

[bumclouds]

guys did you see that massive volume today??! holy crap!

does anyone have idea what's gunna happen?

 

[blackjack]

guys did you see that massive volume today??! holy crap!

does anyone have idea what's gunna happen?

The following releases have been posted to the Starpharma website:

1. Orbis increases its stake in Starpharma to 8.71%
click here to view this file

2. Bioshares Issue 363: SPL: Five Stocks to accumulate in the Weakened Market
click here to view this file

starpharma

I have been accumulating as SPL has many products its working on and most dont need FDA approval and are placed in a billion dollar arena ie animal medicines, herbicides, beauty products.

Bioshares says it best

 

[blackjack]

The following releases have been posted to the Starpharma website:

1. Orbis increases its stake in Starpharma to 8.71%
click here to view this file

2. Bioshares Issue 363: SPL: Five Stocks to accumulate in the Weakened Market
click here to view this file

starpharma

I have been accumulating as SPL has many products its working on and most dont need FDA approval and are placed in a billion dollar arena ie animal medicines, herbicides, beauty products.

Bioshares says it best

SPL has agreements in place with SSL the DUREX condom maker
a take ever over is on the table for SSL and the price is over 30% premium
SPL stocks went up from 49 cents to 54 cents just now
should jump some more tomorrow when the USA markets open

 

[ocelot]

There has been a large increase and alot of buying. Anyone can shed any light?

 

[blackjack]

There has been a large increase and alot of buying. Anyone can shed any light?

I cant believe this forum is so behind

Starpharma has shot up and will be getting royalties this year from the Durex SSL R&B mob -

Also news of working on RoundUp for the Monsanto multi billion dollar company
looks like they have found a way to make RoundUp more soluable

ALL good stuff and plenty of upside

 

[blackjack]

I cant believe this forum is so behind

Starpharma has shot up and will be getting royalties this year from the Durex SSL R&B mob -

Also news of working on RoundUp for the Monsanto multi billion dollar company
looks like they have found a way to make RoundUp more soluable

ALL good stuff and plenty of upside

this Rickett condom coating deal if OFF
the share price has plummeted
i sold out
many questions now being asked on other forums
educate yourself
DYOR
not happy with them now as all info from SPL seems to be toooooooooo optimistic and the CEO has just terminated agreements with DUREX - so although not confirmed the royalty payment from them and much touted may not happen
very disappointing

 

[blackjack]

this Rickett condom coating deal if OFF
the share price has plummeted
i sold out
many questions now being asked on other forums
educate yourself
DYOR
not happy with them now as all info from SPL seems to be toooooooooo optimistic and the CEO has just terminated agreements with DUREX - so although not confirmed the royalty payment from them and much touted may not happen
very disappointing

STILL no good news from SPL
with the doom and gloom from EU and USA i think this stock will go down further
less than $1 i may MAY enter again
however with no royalties and not even into phase 111 I am putting my money into other shares = gold silver

 

[blackjack]

STILL no good news from SPL
with the doom and gloom from EU and USA i think this stock will go down further
less than $1 i may MAY enter again
however with no royalties and not even into phase 111 I am putting my money into other shares = gold silver

From the latest info it would seem that the Vivagel as a condom coating for Ansell is 12 months away. All the testing, compatibility, marketing that was done with Durex now needs to be done with Ansell. Very disappointing and further delays could mean that SPL will need to raise more funds with another share issue. This will no doubt dilute the SP even further.

Certainly one to keep your eye on at 80 -90 cents

 

[StevieY]

Does anyone think SPL is a worth buy? Any thoughts?

Understand that the recent phase 3 trial wasn't too successful.

Thanks
Steve

 

[Gringotts Bank]

Does anyone think SPL is a worth buy? Any thoughts?

Understand that the recent phase 3 trial wasn't too successful.

Thanks
Steve

There was some report out today from a broker targeting $1.79 share price, but I've never heard of them before so I wouldn't give that much credence.

A break of 1.18 to the upside would signal some sort of effort to close the huge gap. I'd be more focused on that and have a conditional buy at 1.185.

 

[StevieY]

There was some report out today from a broker targeting $1.79 share price, but I've never heard of them before so I wouldn't give that much credence.

A break of 1.18 to the upside would signal some sort of effort to close the huge gap. I'd be more focused on that and have a conditional buy at 1.185.

Thanks for that Gringotts Bank!

I've been looking at this since March when it was $1.7...dropped quite a bit since then...

 

[Faramir]

VivaGel condom receives TGA Device Certification

http://www.starpharma.com/news/201

And more news
http://www.abc.net.au/news/2014-07-21/starpharma-ansell-get-approval-for-hiv-fighting-condom/5612430

I have been watching this company since April this year. I am very impressed with Jackie Fairley CEO. I have been watching the share price drop over the past 3 months. I like lots of things about this company. The main reason why I haven't brought any shares is: the company makes a loss.

This would have been my Speculation Stock. I was going to buy a minimum amount last Friday but I brought Veda instead and stayed stucked on Veda. By the time I thought about Starpharma, the stock market closed. Today I was so busy again and then I found out about this announcement and the share price increased by 20% from $0.58 to $0.70.

Did I missed out? I believe Starpharma will make a profit but when? I am not prepared to buy at $0.70. Maybe that would look like a good price next year? Do I wait until August when they report their earnings?

Please read
https://www.aussiestockforums.com/forums/showthread.php?t=28514&page=5&p=833533#post833533

and advised how it can applied to this stock.

I brought a biotech that was making profits for a number of years back in March but it's share price has nearly halved. Starpharma makes a loss but it increased 20% today.

Not sure how I should feel? Maybe let this one go?

 

[Faramir]

Things are looking good for VivaGel. Their other products include: Dendrimer Drug Delivery (DEP™) which sounds promising. This product is "in partnership with pharmaceutical companies including Lilly, GSK’s Stiefel and a number of other undisclosed partners." I think this product is in Phrase One Clinical Trial.
The other product Transfection Reagents, Starpharma is looking for another partner.

10 April, Dr Jackie Fairley appeared on ABC TV "The Business". I thought that she gave a great interview and I since googled her achievements.

What I do not understand?
1): Share Price: reached a high $1.88 back in the week ending 30/4/2012 during the early stages of VivaGel. Massive drop to $0.95 26/11/2012. Lowest recent mark $0.535 19/6/2014. I was seriously considering a very small parcel. Now at $0.72 for a company that hasn't turn a profit yet?? How did it go to $1.88 back in April 2012?

2): Robert Thomas buys 50,000 units 23/6/2014, another 50,000 units 24,000 24/6/2014 which is fair enough considering the low price for this year. Dr Jackie Fairley sells 220,000 @ 25/6/2014, 40,000 @ 26/6/2014 and 100,000 @ 27/6/2014. I thought if Dr J Fairley is selling, maybe there is another drop on the way??? Another reason why I never took action during late June, early July.

Allan Gray is a substantial holder. They must see something I can't see. They are contrarian investors.

My next action??? Just sit, watch and wait for their annual report??